A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a post hoc analysis of the RE-DUAL PCI trial

Autor: Zwart, Bastiaan, Bor, Willem Lambertus, de Veer, Anne Johanna Wilhelmina Maria, Mahmoodi, Bakhtawar Khan, Kelder, Johannes Christiaan, Lip, Gregory Y.H., Bhatt, Deepak L., Cannon, Christopher P., Ten Berg, Jurriën Maria

Publikováno v: Eurointervention, 18(4), E292-e302. Europa Digital & Publishing
Zwart, B, Bor, W L, de Veer, A J W M, Mahmoodi, B K, Kelder, J C, Lip, G Y H, Bhatt, D L, Cannon, C P & Ten Berg, J M 2022, ' A novel risk score to identify the need for triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention : a post hoc analysis of the RE-DUAL PCI trial ', EuroIntervention, vol. 18, no. 4, pp. e292-e302 . https://doi.org/10.4244/EIJ-D-21-00165

BACKGROUND: Current guidelines recommend treating atrial fibrillation (AF) patients who undergo percutaneous coronary intervention (PCI) with triple antithrombotic therapy (TAT) for up to one month in patients at high thrombotic risk. It is unclear h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2b45bd4e855c11ac64bb3932d563767
https://doi.org/10.4244/eij-d-21-00165

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Towards Personalized Medicine Based on Platelet Function Testing for Stent Thrombosis Patients

Autor: Godschalk, Thea Cornelia, Hackeng, Christian Marcus, ten Berg, Jurriën Maria

Publikováno v: Thrombosis.

Stent thrombosis (ST) is a severe and feared complication of coronary stenting. Patients who have suffered from ST are usually treated according to the “one-size-fits-all” dosing regimen of aspirin and clopidogrel. Many ST patients show high on-t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=hindawi_publ::aed1e3b28e6cf4d3a4f405ac05646de3